Terms: = Endocrine gland cancer AND NCOR1, hCIT529I10, 9611, ENSG00000141027, N-CoR, MGC104216, TRAC1, O75376, hN-CoR, KIAA1047
11 results:
1. Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer.
Wen H; Feng Z; Ma Y; Liu R; Ou Q; Guo Q; Shen Y; Wu X; Shao Y; Bao H; Wu X
BMC Cancer; 2022 May; 22(1):550. PubMed ID: 35578198
[TBL] [Abstract] [Full Text] [Related]
2. Synchronous detection of pancreatic adenocarcinoma and paraganglioma in a Whipple resection specimen.
Aaquist T; Dembic M; Thomassen M; de Stricker K; Bertelsen M; Christensen LG; Mortensen MB; Detlefsen S
Pathol Res Pract; 2021 Oct; 226():153590. PubMed ID: 34454393
[TBL] [Abstract] [Full Text] [Related]
3. The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y; Zhang X; Wang O; Bi Y; Xing X; Cui M; Wang M; Tao W; Liao Q; Zhao Y
Int J Cancer; 2020 Nov; 147(9):2446-2457. PubMed ID: 32574388
[TBL] [Abstract] [Full Text] [Related]
4. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
Xing M; Alzahrani AS; Carson KA; Viola D; Elisei R; Bendlova B; Yip L; Mian C; Vianello F; Tuttle RM; Robenshtok E; Fagin JA; Puxeddu E; Fugazzola L; Czarniecka A; Jarzab B; O'Neill CJ; Sywak MS; Lam AK; Riesco-Eizaguirre G; Santisteban P; Nakayama H; Tufano RP; Pai SI; Zeiger MA; Westra WH; Clark DP; Clifton-Bligh R; Sidransky D; Ladenson PW; Sykorova V
JAMA; 2013 Apr; 309(14):1493-501. PubMed ID: 23571588
[TBL] [Abstract] [Full Text] [Related]
5. Development and internal validation of an adrenal cortical carcinoma prognostic score for predicting the risk of metastasis and local recurrence.
Freire DS; Siqueira SA; Zerbini MC; Wajchenberg BL; CorrĂȘa-Giannella ML; Lucon AM; Pereira MA
Clin Endocrinol (Oxf); 2013 Oct; 79(4):468-75. PubMed ID: 23444945
[TBL] [Abstract] [Full Text] [Related]
6. Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis.
Bremmer F; Thelen P; Pottek T; Behnes CL; Radzun HJ; Schweyer S
Anticancer Res; 2012 Jan; 32(1):341-9. PubMed ID: 22213325
[TBL] [Abstract] [Full Text] [Related]
7. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
Sasaki H; Hayakawa J; Terai Y; Kanemura M; Tanabe-Kimura A; Kamegai H; Seino-Noda H; Ezoe S; Matsumura I; Kanakura Y; Sakata M; Tasaka K; Ohmichi M
Oncogene; 2008 Apr; 27(19):2737-45. PubMed ID: 18193094
[TBL] [Abstract] [Full Text] [Related]
8. Clinical and molecular features of a TSH-secreting pituitary microadenoma.
Usui T; Izawa S; Sano T; Tagami T; Nagata D; Shimatsu A; Takahashi JA; Naruse M
Pituitary; 2005; 8(2):127-34. PubMed ID: 16379036
[TBL] [Abstract] [Full Text] [Related]
9. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract] [Full Text] [Related]
10. Differential expression of an orphan receptor COUP-TFI and corepressors in adrenal tumors.
Shibata H; Ando T; Suzuki T; Kurihara I; Hayashi K; Hayashi M; Saito I; Kawabe H; Tsujioka M; Mural M; Saruta T
Endocr Res; 1998; 24(3-4):881-5. PubMed ID: 9888593
[TBL] [Abstract] [Full Text] [Related]
11. COUP-TFI expression in human adrenocortical adenomas: possible role in steroidogenesis.
Shibata H; Ando T; Suzuki T; Kurihara I; Hayashi K; Hayashi M; Saito I; Murai M; Saruta T
J Clin Endocrinol Metab; 1998 Dec; 83(12):4520-3. PubMed ID: 9851803
[TBL] [Abstract] [Full Text] [Related]